UFPTHealthcare · Medical DevicesThe 4 Wall Street analysts covering UFP Technologies, Inc. hold a median 12-month price target of $355 — +7.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 86 of 100 as at 4 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores UFP Technologies, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (93): The share count has been shrinking and the company is not leaning on new borrowing.
Accruals (35): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (32): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on UFPT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +7.6% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 6 Aug 2025 | Lake Street | Maintains | Buy | $252 → $289 |
| 28 Mar 2025 | Raymond James | Initiates | Market Perform | — |
| 17 July 2024 | Lake Street | Maintains | Buy | — |
| 2 July 2024 | Lake Street | Maintains | Buy | — |
| 28 June 2024 | Lake Street | Maintains | Buy | — |
| 20 Mar 2024 | CJS Securities | Initiates | Market Outperform | — |
| 6 Feb 2024 | Keybanc | Initiates | Sector Weight | — |
| 26 June 2023 | Lake Street | Maintains | Buy | — |
| 3 May 2023 | Lake Street | Maintains | Buy | — |
| 8 Mar 2023 | Lake Street | Maintains | Buy | — |
| 22 June 2022 | Lake Street | Initiates | Buy | — |
| 19 Nov 2021 | Colliers Securities | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
UFPT appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, UFP Technologies, Inc. returned +47.9% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 25% of US stocks
Cheaper than 34% of US stocks
Cheaper than 20% of US stocks
Cheaper than 15% of US stocks
Higher than 63% of US stocks
Higher than 60% of US stocks
Higher than 33% of US stocks
Higher than 74% of US stocks
Higher than 72% of US stocks
Higher than 77% of US stocks
Higher than 90% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
UFP Technologies, Inc. has a market value of $2.2B and an enterprise value of $2.3B.
Revenue in the twelve months to 30 June 2026: $631.6M. The latest quarter grew 15.1% year on year.
Net income over the same four quarters: $72.3M, a 11.4% net margin.
Diluted earnings per share, trailing twelve months: $9.28.
Free cash flow in the twelve months to 30 June 2026: $61.4M.
Trailing P/E: 30.5×; forward P/E: 23.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
UFP Technologies, Inc. employs 4,846 people — $130K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own UFP Technologies, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
UFP Technologies reported third-quarter sales of $172.4 million, up 11.6%. Gross margin rose to 29.4% from 27.7% a year earlier.
Why it matters — The reported sales growth and higher gross margin are key operating results for investors monitoring UFPT.
UFP Technologies reported third-quarter 2026 sales growth of 11.6%, citing broad demand across its medical technology portfolio. Management also discussed investments in capacity, operational improvements and acquisitions heading into 2027.
Why it matters — The update highlights demand trends and the areas of investment and growth management is pursuing.
UFP Technologies held its Q3 2026 earnings conference call on November 4, 2026. The excerpt lists company and conference-call participants but provides no financial results or management commentary.
Why it matters — UFPT watchers can note the call took place, but this excerpt does not provide details to assess quarterly performance.
UFP Technologies reported quarterly earnings of $2.88 per share, above the Zacks consensus estimate of $2.63. Earnings were $2.39 per share in the year-ago quarter.
Why it matters — The results show UFPT exceeded the cited earnings estimate and reported higher per-share earnings than a year earlier.
UFP Technologies reported third-quarter 2026 net income of $20.6 million, up 25.8% from $16.4 million in the third quarter of 2025. The excerpt also reports net sales of $172.4 million for the quarter.
Why it matters — The reported increase in quarterly net income and the stated sales figure provide UFPT watchers with an update on the company’s results.
The 4 Wall Street analysts covering UFP Technologies, Inc. have a median 12-month price target of $355, with estimates ranging from $350 to $360. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 4 analysts covering UFP Technologies, Inc., 2 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks UFP Technologies, Inc. 86 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, UFP Technologies, Inc. ranks 86 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (93 of 100).
No one can know that. What the data says: the median 12-month target from 4 analysts implies +7.6% from the last close, and Ticker Nerd's factor model ranks UFP Technologies, Inc. 86 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering UFP Technologies, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UFPT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $350 to $360 over the next 12 months.
UFP Technologies, Inc. returned +47.9% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
UFP Technologies Inc. is a contract development and manufacturing organization focused on single-use and single-patient medical devices.
The most recent item we track (The Motley Fool, 5 Nov 2026): "UFP Technologies: 3 Key Takeaways for Long-Term Investors". UFP Technologies reported third-quarter sales of $172.4 million, up 11.6%. Gross margin rose to 29.4% from 27.7% a year earlier.
UFP Technologies Inc. is a contract development and manufacturing organization focused on single-use and single-patient medical devices. UFP Technologies designs and custom manufactures engineered components, subassemblies, packaging, and finished solutions used in areas such as minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. The company also provides sterile packaging and other highly engineered custom products that support medical device manufacturers across the healthcare supply chain. In addition to its core medical business, UFP Technologies serves selected regulated industrial markets with custom materials and protective solutions. Headquartered in Newburyport, Massachusetts, and founded in 1963, UFP Technologies plays a specialized role in outsourced manufacturing by helping customers convert advanced foams, plastics, films, and other materials into application-specific products.
CEO Mr. Mitchell Caplan Rock · 4,846 employees · United States · https://www.ufpt.com
